News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ETEX Corporation to Present at the 9th World Biomaterial Congress



5/23/2012 9:55:23 AM

CAMBRIDGE, Mass., May 22, 2012 /PRNewswire/ -- ETEX Corporation, an advanced biomaterials company, today announced two presentations at the upcoming 9th World Biomaterial Congress, June 1-5, 2012 in Chengdu, China. ETEX will highlight their vertebral augmentation and cell carrier development programs.

Dr. Jerry Chang, Head of R&D of ETEX Corporation, will deliver an oral presentation entitled "Enhanced Calcium Phosphate Cements for Vertebral Augmentation" during Rapid Fire Session (R3), June 3rd 2012. Dr. Chang will highlight an injectable Calcium Phosphate scaffold with superior cancellous bone filling, hard setting, and cell mediated remodeling for bone regeneration in vertebral compression fracture repair applications.

ETEX Corporation scientific team will also showcase recent advancements in their Stem Cell Carrier program during the poster session (R1). The presentation is entitled "Calcium Phosphate Combination Biomaterials as Human Mesenchymal Stem Cell (hMSC) Delivery Vehicles for Bone Repair." This marks ETEX's third presentation regarding their cell carrier platform in the last six months, following oral presentations at the 4th Annual World Congress of Regenerative Medicine & Stem Cell in Beijing, China, and the GTC 8th Stem Cell Summit in Boston, MA.

As a pioneer in implantable biomaterials and the delivery of orthobiologics, such as growth factors and cells, ETEX is excited to participate in this important event.

Brian Ennis, President and CEO of ETEX Corporation, comments: "ETEX is eager to highlight two important development platforms at the upcoming World Biomaterial Congress in Chengdu. The setting is particularly relevant as ETEX is collaborating with leading centers in China to further document the clinical efficacy of ETEX biomaterials. This collaborative initiative will result in additional clinical documentation and lead to commercialization of our leading orthobiologic platforms in the rapidly expanding Chinese orthopedic market."

About ETEX Corporation

Established in 1989, ETEX Corporation develops, manufactures and commercializes calcium phosphate-based biomaterials for improved orthopedic clinical outcomes. A leader in bioresorbable bone substitute materials, ETEX focuses on expanding applications through combinations with cells, biologics, or therapeutic agents delivered in minimally invasive and easy to use systems. For more information, visit www.etexcorp.com.

SOURCE ETEX Corporation


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES